Liz Morrell
MA MSc PhD FHEA
Senior Researcher
Liz joined Health Economics Research Centre (HERC) in February 2018, from the Centre for the Advancement of Sustainable Medical Innovation (CASMI) - a policy research group in Oxford’s Radcliffe Department of Medicine.
She is working with Sarah Wordsworth and colleagues, initially on a series of Discrete Choice Experiments exploring clinician and public attitudes to antibiotics and antimicrobial resistance.
Her work focused on the health economics of cancer drugs, exploring the impact of technology appraisal processes on patient access to drugs, and the value that society places on treating cancer relative to other conditions.
Before joining CASMI, Liz worked as a freelance researcher with clients in pharmaceuticals and education, and as a product development manager in consumer healthcare.
Recent publications
-
Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumour DNA: a Comparative Microcosting Study
Journal article
MORRELL L. et al, (2025), Value in Health Regional Issues
-
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.
Journal article
Mawalla WF. et al, (2025), Blood Adv
-
How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare
Journal article
Mcleod M. et al, (2024), BMC Public Health, 24
-
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.
Journal article
Roope LSJ. et al, (2024), Commun Med (Lond), 4
-
Improving the uptake and SusTainability of Effective interventions to promote Prudent antibiotic Use and Primary care (STEPUP): discrete choice experiments
Dataset
MORRELL L., (2023)